C-reactive protein to lymphocyte ratio as a new biomarker in predicting surgical site infection after posterior lumbar interbody fusion and instrumentation

被引:7
作者
Wu, Xiaofei [1 ]
Ma, Xun [1 ]
Zhu, Jian [1 ,2 ]
Chen, Chen [1 ]
机构
[1] Shanxi Med Univ, Shanxi Bethune Hosp, Hosp 3, Taiyuan, Peoples R China
[2] Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Shijiazhuang, Peoples R China
来源
FRONTIERS IN SURGERY | 2022年 / 9卷
关键词
posterior lumbar interbody fusion; perioperative management; risk prediction tool; creative protein to lymphocyte count ratio (CLR); surgical site infection; DEEP WOUND-INFECTION; INFLAMMATION; CRP/ALBUMIN; DIAGNOSIS; OUTCOMES; MARKER; HEALTH; LEVEL; COUNT;
D O I
10.3389/fsurg.2022.910222
中图分类号
R61 [外科手术学];
学科分类号
摘要
PurposeThis study aims to evaluate the potential of C-reactive protein to lymphocyte count ratio (CLR) for the prediction of surgical site infection (SSI) following posterior lumbar interbody fusion (PLIF) and the instrumentation of lumbar degenerative diseases. MethodsIn this retrospective study, we considered patients with a lumbar degenerative disease diagnosis surgically treated by the instrumented PLIF procedure from 2015 to 2021. Patient data, including postoperative early SSI and other perioperative variables, were collected from their respective hospitalization electronic medical records. The receiver operator characteristic curve was constructed to determine the optimal cut-off value for CLR, and the ability to predict SSI was evaluated by the area under the curve (AUC). According to the cut-off value, patients were dichotomized with high- or low-CLR, and between-group differences were compared using univariate analysis. The independent impact of CLR on predicting SSI was investigated by multivariate logistics regression analysis. ResultsA total of 773 patients were included, with 26 (3.4%) developing an early SSI post-operation. The preoperative CLR was 11.1 +/- 26.1 (interquartile range, 0.4-7.5), and the optimal cut-off was 2.1, corresponding to a sensitivity of 0.856, a specificity of 0.643, and an AUC of 0.768 (95% CI, 0.737-0.797). CLR demonstrated a significantly improved prediction ability than did lymphocyte count (P = 0.021) and a similar ability to predict an infection as C-response protein (P = 0.444). Patients with a high CLR had a significantly higher SSI incidence than those with a low CLR (7.6% vs. 0.8%, P < 0.001). After adjustment for numerous confounding factors, CLR >= 2.1 was associated with an 11.16-fold increased risk of SSI, along with other significant variables, i.e., diabetes, preoperative waiting time, and surgical duration. ConclusionA high CLR exhibited an improved ability to predict incident SSI and was associated with a substantially increased risk of SSI following instrumented PLIF. After better-design studies verified this finding, CLR could potentially be a beneficial tool in surgical management.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] C-reactive protein/albumin ratio is a prognostic indicator for predicting surgical intervention and mortality in neonates with necrotizing enterocolitis
    Mohd Amin, Amir T.
    Zaki, Rafdzah A.
    Friedmacher, Florian
    Sharif, Shazia P.
    PEDIATRIC SURGERY INTERNATIONAL, 2021, 37 (07) : 881 - 886
  • [42] Single-use instrumentation in posterior lumbar fusion could decrease incidence of surgical site infection: a prospective bi-centric study
    Litrico S.
    Recanati G.
    Gennari A.
    Maillot C.
    Saffarini M.
    Le Huec J.-C.
    European Journal of Orthopaedic Surgery & Traumatology, 2016, 26 (1) : 21 - 26
  • [43] C-reactive protein, white blood cells, and neutrophil/lymphocyte ratio for predicting complicated appendicitis: which is more reliable?
    Casas, Maria A.
    Angeramo, Cristian A.
    Lezama, Manuela Monrabal
    Rotholtz, Nicolas A.
    Schlottmann, Francisco
    JOURNAL OF GASTROINTESTINAL SURGERY, 2024, 28 (10) : 1704 - 1705
  • [44] Neutrophil-to-lymphocyte ratio in predicting mortality in sepsis and its correlation with sofa score and C-reactive protein values
    Nayak, Smriti S.
    Behera, Bijaya K.
    Thatoi, Pravat K.
    Mohanty, Nihar R.
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2025, 14 (03) : 839 - 849
  • [45] Role of Postoperative C-Reactive Protein Levels in Predicting Prognosis After Surgical Treatment of Esophageal Cancer
    Ibuki, Yuta
    Hamai, Yoichi
    Hihara, Jun
    Emi, Manabu
    Taomoto, Junya
    Furukawa, Takaoki
    Yamakita, Ichiko
    Kurokawa, Tomoaki
    Okada, Morihito
    WORLD JOURNAL OF SURGERY, 2017, 41 (06) : 1558 - 1565
  • [46] C-reactive protein to lymphocyte count ratio is a promising novel marker in hepatitis C infection: the clear hep-c study
    Demirkol, Muhammed Emin
    Aktas, Gulali
    Bilgin, Satilmis
    Kahveci, Gizem
    Kurtkulagi, Ozge
    Atak, Burcin Meryem
    Duman, Tuba Taslamacioglu
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2022, 68 (06): : 838 - 841
  • [47] The Significance of Serum C-Reactive Protein and Neutrophil-Lymphocyte Ratio in Predicting the Diagnostic Outcomes of Renal Mass Biopsy Procedure
    Colakerol, Aykut
    Sahin, Sergen
    Yazar, Ramazan Omer
    Temiz, Mustafa Zafer
    Yuruk, Emrah
    Kandirali, Engin
    Semercioz, Atilla
    Muslumanoglu, Ahmet Yaser
    JOURNAL OF KIDNEY CANCER AND VHL, 2023, 10 (01): : 9 - 14
  • [48] Radiographic spine adipose index: an independent risk factor for deep surgical site infection after posterior instrumented lumbar fusion
    Gupta, Vikesh Kumar
    Zhou, Yuxuan
    Manson, Jonathan Francis
    Watt, James Peter
    SPINE JOURNAL, 2021, 21 (10) : 1711 - 1717
  • [49] C-Reactive Protein and Neutrophil to Lymphocyte Ratio Values in Predicting Inhospital Death in Patients with Stanford Type A Acute Aortic Dissection
    Erdolu, Burak
    Kagan, Ahmet
    HEART SURGERY FORUM, 2020, 23 (04) : E488 - E492
  • [50] Preoperative high-sensitivity C-reactive protein to lymphocyte ratio index plays a vital role in the prognosis of hepatocellular carcinoma after surgical resection
    Liao, Minjun
    Chen, Pu
    Liao, Yan
    Li, Jun
    Yao, Wenmin
    Sun, Tian
    Liao, Weijia
    Su, Lili
    ONCOTARGETS AND THERAPY, 2018, 11 : 5591 - 5600